Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis

BACKGROUND/AIMS: To investigate the efficacy and safety of tocilizumab (TCZ) humanized anti-interleukin-6 receptor monoclonal antibody, in Korean patients with active rheumatoid arthritis (RA) refractory to conventional disease modifying anti-rheumatic drugs (DMARDs) including methotrexate (MTX) MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Han Joo, Lim, Mie Jin, Park, Won, Park, Sung Hwan, Shim, Seung-Cheol, Yoo, Dae-Hyun, Kim, Hyun Ah, Lee, Soo Kon, Lee, Yun Jong, Park, Young Eun, Cha, Hoon-Suk, Song, Yeong-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610180/
https://www.ncbi.nlm.nih.gov/pubmed/29334721
http://dx.doi.org/10.3904/kjim.2017.159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610180/
https://www.ncbi.nlm.nih.gov/pubmed/29334721
http://dx.doi.org/10.3904/kjim.2017.159

Ejemplares similares